Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Cronos Group Inc. (CRON) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/12/2019 6-K Quarterly results
11/12/2019 6-K Quarterly results
10/25/2019 6-K Quarterly results
10/16/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Issues Statement on Separately Announced IPO of Cronos Australia"
10/11/2019 6-K Quarterly results
09/30/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Announces Appointment of Jody Begley to Board of Directors"
09/26/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
09/05/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Material Change Report of Cronos Group Inc."
09/05/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. Closes Redwood Holding Group Acquisition"
08/26/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. CEO, Mike Gorenstein, to Present at Barclays 2019 Global Consumer Staples Conference"
08/23/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. Enters into Credit Agreement with Cronos Growing Company Inc. TORONTO, Aug. 23, 2019 -- Cronos Group Inc. has entered into a credit agreement , as administrative agent and lender, with Cronos Growing Company Inc. , as borrower, in respect of a $100 million secured non-revolving term loan credit facility . Cronos GrowCo, a 50/50 joint venture owned by Cronos Group and a group of investors led by Bert Mucci , intends to use the funds available under the Credit Facility to fund the construction of the previously announced custom-built greenhouse and for general operating purposes. Completion of construction of the Facility is subject to obtaining the relevant building and occupancy permits and other customary approvals. Commencement of operations at Cronos GrowCo will be su..."
08/08/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Unaudited Condensed Interim Consolidated Financial Statements",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations",
"Form 52-109F2 – Certification of Interim Filings Full Certificate – Chief Executive Officer",
"Form 52-109F2 – Certification of Interim Filings Full Certificate – Chief Financial Officer"
08/08/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. Announces Second Quarter and First-Half 2019 Results"
08/02/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Membership Interest Purchase Agreement",
"Material Change Report of Cronos Group Inc."
08/02/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform"
07/11/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Enters Agreement to Acquire State-of-the-Art Fermentation and Manufacturing Facility"
07/09/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Appoints Dr. Todd Abraham as Chief Innovation Officer 36-Year CPG Executive Brings Extensive Experience in Identifying, Developing and Commercializing Breakthrough Technology for Consumer Goods Sector"
07/08/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. to Hold Second Quarter 2019 Earnings Conference Call"
05/30/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. to Present at Piper Jaffray 39th Annual Consumer Marketplace Conference, Jefferies 2019 Healthcare Conference and Stifel 2019 Cross Sector Insight Conference"
05/29/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. Sets Date for 2019 Annual Meeting of Shareholders TORONTO, May 29, 2019 -- Cronos Group Inc. , an innovative global cannabinoid company, will hold its 2019 Annual Meeting of Shareholders on Wednesday, June 19, 2019 at 10 a.m. ET at the offices of Blake, Cassels & Graydon LLP located at 199 Bay Street, Suite 4000, Commerce Court West, Toronto. The Notice of Meeting and Management Information Circular are available on the Governance section of the Company’s website at https://ir.thecronosgroup.com/investor-relations. A live audio webcast and replay of the meeting will also be available in the Investor Relations section of the Company’s website. To listen live, please use the following link: https://edge.media-server.com/m6/p/ygzka7zy Cronos Group is an innovative global ca..."
05/28/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Notice of Meeting and Management Information Circular for the Annual Meeting of Shareholders to be Held on June 19, 2019",
"Form of Proxy",
"Voting Instruction Form"
05/14/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement TORONTO, May 14, 2019 -- Cronos Group Inc. , is pleased to announce that it has entered into a multi-year supply agreement with MediPharm Labs Corp. . MediPharm Labs will supply Cronos Group with approximately $30 million of high-quality private label cannabis concentrate over 18-months, and, subject to certain renewal and purchase options, potentially up to $60 million over 24-months. In addition, Cronos Group and MediPharm Labs have entered into a multi-year tolling agreement, where Cronos Group will supply bulk cannabis to MediPharm Labs’ state of the art extraction facility in Barrie, Ontario, to fulfill certain additional process..."
05/09/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Unaudited Condensed Interim Consolidated Financial Statements",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations",
"Form 52-109F2 – Certification of Interim Filings Full Certificate – Chief Executive Officer",
"Form 52-109F2 – Certification of Interim Filings Full Certificate – Chief Financial Officer"
05/09/2019 6-K Quarterly results
Docs: "FORM 6-K",
"Cronos Group Inc. Announces First Quarter 2019 Results"
05/07/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids"
04/09/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. to Hold Conference Call on First Quarter 2019 Financial Results TORONTO, April 09, 2019 -- Cronos Group Inc. , will announce its financial results for the first quarter ended March 31, 2019, and hold its First Quarter 2019 Earnings Conference Call on Thursday, May 9, 2019 at 8:30 a.m. EDT. Senior management will be available for questions from the investment community after prepared remarks. A live audio webcast of the earnings call will be available on the Company’s website at https://ir.thecronosgroup.com/events-presentations. Participants may also listen via telephone by dialing 795-2258 toll-free from the U.S. and Canada, or 937-8902 if dialing from outside the U.S. and Canada. The call will be archived on the Company’s website for replay. Cronos Group is an innovati..."
03/26/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results"
03/15/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Investor Rights Agreement, by and between Cronos Group Inc. and Altria Group, Inc",
"Material Change Report of Cronos Group Inc."
03/08/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc."
03/04/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. Exits Investment in Whistler Medical Marijuana Corporation TORONTO, March 04, 2019 -- Cronos Group Inc. , confirmed today that it has sold all of its common shares in the capital of Whistler Medical Marijuana Corporation , representing approximately 19 percent of Whistler’s issued and outstanding common shares, to Aurora Cannabis Inc. for a total purchase price of approximately C$175 million, payable by the issuance of common shares in the capital of Aurora , and subject to certain working capital adjustments and holdbacks . “We’d like to thank and congratulate Whistler for their partnership over the past two years,” said Mike Gorenstein, CEO of Cronos Group. “Whistler’s commitment to creating high-quality products and establishing a premium brand has generated value for..."
03/01/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. to Hold Full Year and Fourth Quarter 2018 Earnings Conference Call"
02/21/2019 6-K Quarterly results
01/23/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cronos Group Inc. Announces Closing of"
01/18/2019 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Notice of Meeting and Management Information Circular for the Special Meeting of Shareholders to be Held on February 21, 2019",
"Form of Proxy",
"Certificate of Abridgement",
"Cronos Group Inc. Announces Mailing of Meeting Materials in Connection with Upcoming Special Meeting of Shareholders TORONTO, January 18, 2019 - Cronos Group Inc. is pleased to announce that the meeting materials for a special meeting of holders of common shares of the Company to be held on February 21, 2019 , including the management proxy circular dated December 31, 2018 , prepared in connection with the proposed C$2.4 billion equity investment by Altria Group, Inc. in Cronos Group previously announced on December 7, 2018, have been mailed to Shareholders and filed with the relevant Canadian securities regulators. Board Recommendation As previously announced, the Board of Directors of Cronos Group, after consultation with its legal and financial advisors, has unanimously determined tha..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy